illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Medistim
Company logo

Medistim | Sustainability Performance

https://www.medistim.com
Linkedin

Medistim ASA specializes in medical technology and devices. The company provides solutions aimed at improving surgical procedures and patient outcomes, focusing on innovative applications in healthcare.

1984

Norway

501 - 1,000 employees

Medical Device

$25M - 100M in revenue

$1M - 10M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#4882
Overall
#93
in Norway
#62
in Medical Device

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Navamedic

Norway, Hospital & Health Care, Pharmaceuticals


Company logo
ArcticZymes Technologies

Norway, Hospital & Health Care, Biotechnology


Company logo
BerGenBio

Norway, Hospital & Health Care, Biotechnology

Market cap

49.5B $, 2026▲0% YoY

Revenue

67.3M $, 2025▲19.6% YoY

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Medistim's intraoperative ultrasound devices require rigorous quality control, and any calibration error could affect surgical outcome accuracy.
Powered by illuminem

Market cap

49.5B $, 2026▲0% YoY

Revenue

67.3M $, FY2025▲19.6% YoY

EBITDA

18.9M $, FY2025▼9.1% YoY

Operating margin

28% Industry: -136▲16.9% YoY

Revenue & EBITDA

$67.3MFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

11.4M 2024▲29.5% YoY

Capex

2.3M 2024▼20.8% YoY

Return on invested capital

34.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.1

▲ 0.8%

2023

0.1

▲ 2.7%

2024

0.1

▲ 0.9%

2025

0.9

2028

Powered by illuminem

Sustainability targets and commitments

TargetYearValueScopeBaseline

Progress against targets

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Not available

Recycling policy

Not available

Workplace health & safety policy

Not available

17%
Independent Directors

3 out of 18 incl. management

Powered by illuminem

Overall score

0

Environment

0

Social

0

Governance

0

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Sustainability employees


Total sustainability employees

4-6


    Available in
    Scale package

    Access
  • Email

  • Email